IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 267 filers reported holding IVERIC BIO INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $132,363,364 | +308.2% | 3,364,600 | +152.5% | 0.29% | +259.3% |
| Q1 2023 | $32,425,394 | +79.6% | 1,332,733 | +58.0% | 0.08% | +65.3% |
| Q4 2022 | $18,055,289 | -40.2% | 843,311 | -49.9% | 0.05% | -47.3% |
| Q3 2022 | $30,197,000 | +524.2% | 1,683,235 | +234.7% | 0.09% | +481.2% |
| Q2 2022 | $4,838,000 | +760.9% | 502,893 | +1395.5% | 0.02% | +700.0% |
| Q4 2021 | $562,000 | – | 33,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |